<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">09436</article-id><article-id pub-id-type="doi">10.7554/eLife.09436</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Developmental Biology</subject></subj-group></article-categories><title-group><article-title>Functional genomic screening reveals asparagine dependence as a metabolic vulnerability in sarcoma</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-36205"><name><surname>Hettmer</surname><given-names>Simone</given-names></name><aff><institution content-type="dept">Pediatric Hematology/ Oncology</institution>, <institution>University Medical Center Freiburg</institution>, <addr-line><named-content content-type="city">Freiburg</named-content></addr-line>, <country>Germany</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-36716"><name><surname>Schinzel</surname><given-names>Anna C</given-names></name><aff><institution content-type="dept">Medical Oncology</institution>, <institution>Dana-Farber Cancer Institute</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-36717"><name><surname>Tchessalova</surname><given-names>Daria</given-names></name><aff><institution content-type="dept">Neuroscience Graduate Program</institution>, <institution>University of Michigan</institution>, <addr-line><named-content content-type="city">Ann Arbor</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-44221"><name><surname>Schneider</surname><given-names>Michaela</given-names></name><aff><institution content-type="dept">Pediatric hematology/ oncology</institution>, <institution>University Medical Center Freiburg</institution>, <addr-line><named-content content-type="city">Freiburg</named-content></addr-line>, <country>Germany</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-36718"><name><surname>Parker</surname><given-names>Christina L.</given-names></name><aff><institution content-type="dept">Molecular Pharmaceutics</institution>, <institution>University of North Carolina</institution>, <addr-line><named-content content-type="city">Chapel Hill</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-36719"><name><surname>Bronson</surname><given-names>Roderick</given-names></name><aff><institution content-type="dept">Harvard Medical School</institution>, <institution>Harvard University</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-36720"><name><surname>Richards</surname><given-names>Nigel G.J.</given-names></name><aff><institution content-type="dept">Chemistry &amp; Chemical Biology</institution>, <institution>Indiana University - Purdue University Indianapolis</institution>, <addr-line><named-content content-type="city">Indianapolis</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-5558"><name><surname>Hahn</surname><given-names>William</given-names></name><aff><institution>Dana Farber Cancer Institute</institution>, <addr-line><named-content content-type="city">*</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-10097"><name><surname>Wagers</surname><given-names>Amy J</given-names></name><aff><institution content-type="dept">Harvard Stem Cell Institute</institution>, <institution>Harvard University</institution>, <country>United States</country><email>amy.wagers@joslin.harvard.edu</email></aff><xref ref-type="fn" rid="conf2"/></contrib></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1154"><name><surname>Okano</surname><given-names>Hideyuki</given-names></name><role>Reviewing editor</role><aff><institution>Keio University School of Medicine</institution>, <country>Japan</country></aff></contrib></contrib-group><pub-date date-type="pub" publication-format="electronic"><day>24</day><month>10</month><year>2015</year></pub-date><volume>4</volume><elocation-id>e09436</elocation-id><supplementary-material><ext-link xlink:href="elife-09436-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material><history><date date-type="received"><day>15</day><month>06</month><year>2015</year></date><date date-type="accepted"><day>21</day><month>10</month><year>2015</year></date></history><permissions><copyright-statement>Â© 2015, Hettmer et al</copyright-statement><copyright-year>2015</copyright-year><copyright-holder>Hettmer et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><abstract><p>Current therapies for sarcomas are often inadequate. This study sought to identify actionable gene targets by selective targeting of the molecular networks that support sarcoma cell proliferation. Silencing of asparagine synthetase (ASNS), an amidotransferase that converts aspartate into asparagine, produced the strongest inhibitory effect on sarcoma growth in a functional genomic screen of mouse sarcomas generated by oncogenic Kras and Cdkn2a. ASNS silencing in mouse and human sarcoma cell lines reduced the percentage of S phase cells and impeded new polypeptide synthesis. These effects of ASNS silencing were reversed by exogenous supplementation with asparagine. Also, asparagine depletion via the ASNS inhibitor amino sulfoximine 5 (AS5) or asparaginase inhibited mouse and human sarcoma growth in vitro, and genetic silencing of ASNS in mouse sarcoma cells combined with depletion of plasma asparagine inhibited tumor growth in vivo. Asparagine reliance of sarcoma cells may represent a metabolic vulnerability with potential anti-sarcoma therapeutic value.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd><kwd>Mouse</kwd></kwd-group></article-meta></front><back><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Amy J Wagers, Reviewing editor, eLife.</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All of the animals were handled according to approved institutional animal care and use committee (IACUC) protocols of the Joslin Diabetes Center. The protocol was approved by the Committee on the Ethics of Animal Experiments of the Joslin Diabetes Center. All surgery was performed under tribromoethanol or isoflurane anesthesia, and every effort was made to minimize suffering.</p></fn></fn-group></back></article>